z-logo
open-access-imgOpen Access
Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog
Author(s) -
Hester T. Swelheim,
Ciska Westerlaken,
Evelyn van Pinxteren-Nagler,
Gianni Bocca
Publication year - 2012
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc11-2135
Subject(s) - medicine , glucocorticoid , lipoatrophy , diabetes mellitus , insulin , girl , endocrinology , type 2 diabetes , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , viral load , psychology , developmental psychology
Lipoatrophy has been reported in association with the use of human insulin analogs (1). We report on a girl with severe lipoatrophy who was treated with betamethasone added to the insulin analog, after which the areas of lipoatrophy improved.A 7-year-old girl with type 1 diabetes, treated with insulin-aspart by continuous subcutaneous insulin infusion, developed areas of lipoatrophy at her insulin infusion sites, which initially only involved the buttocks. A few months later, areas of lipoatrophy were also seen on her thighs. The areas of lipoatrophy on her left and right buttocks measured 7 × 7 cm and 7 × 6 cm, respectively. Laboratory investigation excluded the presence of insulin antibodies. A skin biopsy was not performed.Initially, insulin-aspart was substituted with insulin-lispro. Because …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom